Suppr超能文献

揭示变构结合位点:GPCR药物发现的新靶点。

Unmasking allosteric-binding sites: novel targets for GPCR drug discovery.

作者信息

Casadó-Anguera Verònica, Casadó Vicent

机构信息

Laboratory of Molecular Neuropharmacology, Department of Biochemistry and Molecular Biomedicine, Faculty of Biology, Universitat de Barcelona, and Institute of Biomedicine of the Universitat de Barcelona, Barcelona, Spain.

Laboratory of Neuropharmacology-Neurophar, Department of Experimental and Health Sciences, Universitat Pompeu Fabra, Barcelona, Spain.

出版信息

Expert Opin Drug Discov. 2022 Aug;17(8):897-923. doi: 10.1080/17460441.2022.2085684. Epub 2022 Jun 13.

Abstract

INTRODUCTION

Unexpected non-apparent and hidden allosteric-binding sites are non-classical and non-apparent allosteric centers in 3-D X-ray protein structures until orthosteric or allosteric ligands bind to them. The orthosteric center of one protomer that modulates binding centers of the other protomers within an oligomer is also an unexpected allosteric site. Furthermore, another partner protein can also produce these effects, acting as an unexpected allosteric modulator.

AREAS COVERED

This review summarizes both classical and non-classical allosterism. The authors focus on G protein-coupled receptor (GPCR) oligomers as a paradigm of allosteric molecules. Moreover, they show several examples of unexpected allosteric sites such as hidden allosteric sites in a protomer that appear after the interaction with other molecules and the allosterism exerted between orthosteric sites within GPCR oligomer, emphasizing on the allosteric modulations that can occur between binding sites.

EXPERT OPINION

The study of these new non-classical allosteric sites will expand the diversity of allosteric control on the function of orthosteric sites within proteins, whether GPCRs or other receptors, enzymes, or transporters. Moreover, the design of new drugs targeting these hidden allosteric sites or already known orthosteric sites acting as allosteric sites in protein homo- or hetero-oligomers will increase the therapeutic potential of allosterism.

摘要

引言

在正构或变构配体与其结合之前,意外的非表观和隐藏变构结合位点是三维X射线蛋白质结构中的非经典和非表观变构中心。寡聚体中一个原聚体的正构中心调节其他原聚体的结合中心,这也是一个意外的变构位点。此外,另一种伴侣蛋白也可产生这些效应,作为意外的变构调节剂。

涵盖领域

本综述总结了经典和非经典变构作用。作者将G蛋白偶联受体(GPCR)寡聚体作为变构分子的范例进行重点阐述。此外,他们展示了几个意外变构位点的例子,如原聚体中与其他分子相互作用后出现的隐藏变构位点,以及GPCR寡聚体中正构位点之间产生的变构作用,着重介绍了结合位点之间可能发生的变构调节。

专家观点

对这些新的非经典变构位点的研究将扩大对蛋白质(无论是GPCR还是其他受体、酶或转运蛋白)中正构位点功能变构控制的多样性。此外,针对这些隐藏变构位点或在蛋白质同型或异型寡聚体中作为变构位点的已知正构位点设计新药,将增加变构作用的治疗潜力。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验